182 related articles for article (PubMed ID: 31421381)
1. Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and ∆(4)-abiraterone from cancer patients.
Bhatnagar A; McKay MJ; Thaysen-Andersen M; Arasaratnam M; Crumbaker M; Gurney H; Molloy MP
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1126-1127():121741. PubMed ID: 31421381
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry.
Bhatnagar A; McKay MJ; Crumbaker M; Ahire K; Karuso P; Gurney H; Molloy MP
J Pharm Biomed Anal; 2018 May; 154():66-74. PubMed ID: 29533860
[TBL] [Abstract][Full Text] [Related]
3. An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5α-abiraterone, and their inactive glucuronide derivatives.
Caron P; Turcotte V; Lévesque E; Guillemette C
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():249-255. PubMed ID: 30537624
[TBL] [Abstract][Full Text] [Related]
4. An LC-MS/MS method for quantification of the active abiraterone metabolite Δ(4)-abiraterone (D4A) in human plasma.
van Nuland M; Rosing H; de Vries J; Ovaa H; Schellens JHM; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():119-124. PubMed ID: 29059586
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in prostate cancer patients.
Dillenburg Weiss TL; Gössling G; Venzon Antunes M; Schwartsmann G; Linden R; Gasparin Verza S
J Pharm Biomed Anal; 2021 Feb; 195():113861. PubMed ID: 33373824
[TBL] [Abstract][Full Text] [Related]
6. A quick UPLC-MS/MS method for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in human plasma.
Weiss TLD; Furtado CM; Antunes MV; Gössling G; Schwartsmann G; Linden R; Verza SG
Biomed Chromatogr; 2020 Nov; 34(11):e4947. PubMed ID: 32652651
[TBL] [Abstract][Full Text] [Related]
7. Dried Plasma Spot Based LC-MS/MS Method for Monitoring of Meropenem in the Blood of Treated Patients.
Cao H; Jiang Y; Wang S; Cao H; Li Y; Huang J
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335353
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a novel LC-MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation of diastereoisomers without use of a chiral column.
Alyamani M; Li Z; Upadhyay SK; Anderson DJ; Auchus RJ; Sharifi N
J Steroid Biochem Mol Biol; 2017 Sep; 172():231-239. PubMed ID: 27063554
[TBL] [Abstract][Full Text] [Related]
9. A simple, rapid and stability indicating validated method for quantification of lamotrigine in human plasma and dry plasma spot using LC-ESI-MS/MS: Application in clinical study.
Namdev KK; Dwivedi J; Chilkoti DC; Sharma S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():362-369. PubMed ID: 29223050
[TBL] [Abstract][Full Text] [Related]
10. LC-MS/MS-Based Quantification of 9 Antiepileptic Drugs From a Dried Sample Spot Device.
DʼUrso A; Cangemi G; Barco S; Striano P; DʼAvolio A; de Grazia U
Ther Drug Monit; 2019 Jun; 41(3):331-339. PubMed ID: 30688867
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MS.
Kim KP; Parise RA; Holleran JL; Lewis LD; Appleman L; van Erp N; Morris MJ; Beumer JH
J Pharm Biomed Anal; 2017 May; 138():197-205. PubMed ID: 28219796
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an LC-MS/MS Method for the Simultaneous Quantification of Abiraterone, Enzalutamide, and Their Major Metabolites in Human Plasma.
van Nuland M; Hillebrand MJX; Rosing H; Schellens JHM; Beijnen JH
Ther Drug Monit; 2017 Jun; 39(3):243-251. PubMed ID: 28490047
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation.
Linder C; Hansson A; Sadek S; Gustafsson LL; Pohanka A
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():116-122. PubMed ID: 29149735
[TBL] [Abstract][Full Text] [Related]
14. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.
Protti M; Catapano MC; Samolsky Dekel BG; Rudge J; Gerra G; Somaini L; Mandrioli R; Mercolini L
J Pharm Biomed Anal; 2018 Apr; 152():204-214. PubMed ID: 29414014
[TBL] [Abstract][Full Text] [Related]
15. Inter- and intra-patient variability in pharmacokinetics of abiraterone acetate in metastatic prostate cancer.
Arasaratnam M; Crumbaker M; Bhatnagar A; McKay MJ; Molloy MP; Gurney H
Cancer Chemother Pharmacol; 2019 Jul; 84(1):139-146. PubMed ID: 31081533
[TBL] [Abstract][Full Text] [Related]
16. Exposure-response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer.
van Nuland M; Groenland SL; Bergman AM; Steeghs N; Rosing H; Venekamp N; Huitema ADR; Beijnen JH
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):244-251. PubMed ID: 31611636
[TBL] [Abstract][Full Text] [Related]
17. A HPLC-fluorescence method for the quantification of abiraterone in plasma from patients with metastatic castration-resistant prostate cancer.
Belleville T; Noé G; Huillard O; Thomas-Schoemann A; Vidal M; Goldwasser F; Alexandre J; Blanchet B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():86-90. PubMed ID: 25813901
[TBL] [Abstract][Full Text] [Related]
18. Dried plasma spots for therapeutic monitoring of amikacin: Validation of an UHPLC-MS/MS assay and pharmacokinetic application.
da Silva ACC; de Lima Feltraco Lizot L; Bastiani MF; Venzon Antunes M; Brucker N; Linden R
J Pharm Biomed Anal; 2020 May; 184():113201. PubMed ID: 32113122
[TBL] [Abstract][Full Text] [Related]
19. Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma.
Benoist GE; van der Meulen E; Lubberman FJE; Gerritsen WR; Smilde TJ; Schalken JA; Beumer JH; Burger DM; van Erp NP
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28370076
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of valproic acid using a dried plasma spot sampling device.
Li Y; Jiang Y; Cao H; Lin H; Ren W; Huang J; Zhang J
J Mass Spectrom; 2021 Apr; 56(4):e4603. PubMed ID: 33729629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
